ABBOTT INDIA LIMITED
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 523
- Registration Number
- NCT00156195
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 432
- Registration Number
- NCT00160381
Study of Asoprisnil in the Treatment of Uterine Fibroids.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 149
- Registration Number
- NCT00156156
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 131
- Registration Number
- NCT00160433
Treatment of Uterine Fibroids With Asoprisnil(J867)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 475
- Registration Number
- NCT00152269
A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 18
- Registration Number
- NCT00152295
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 105
- Registration Number
- NCT00152282
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-09
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 239
- Registration Number
- NCT00152256
A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 33
- Registration Number
- NCT00150644
A Long Term Safety Study With Atrasentan
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2007-11-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 166
- Registration Number
- NCT00127478
- Locations
- 🇺🇸
University of Pittsburgh Department of Urology, Pittsburgh, Pennsylvania, United States
🇺🇸South Florida Medical Research, Aventura, Florida, United States
🇺🇸Prostate Oncology Specialists, Marina Del Rey, California, United States
© Copyright 2024. All Rights Reserved by MedPath